Update: 12.08.2025
Last week: 31 week 2025 (28.07.2025 - 03.08.2025)
Last full month: July 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 672 | 3.0% | 14.1% | 0.4 | 17 856 593 | 2.7% | 10.7% | 0.3 | -0.1% |
| MoM | 35 432 | -4.8% | 14.0% | 0.2 | 82 298 386 | -4.1% | 10.7% | 0.2 | -6.4% |
| YTD | 276 543 | 23.3% | 13.1% | 1.6 | 615 025 058 | 27.2% | 9.8% | 0.4 | 8.0% |
| MAT | 473 622 | 25.5% | 13.2% | 2.6 | 970 736 596 | 22.3% | 9.6% | 0.7 | 0.5% |
| BRAINMAX | |||||||||
| WoW | 1 878 | 3.6% | 100.0% | 0 | 6 570 590 | 5.5% | 100.0% | 0 | 3.6% |
| MoM | 8 367 | -9.6% | 100.0% | 0 | 28 979 330 | -8.5% | 100.0% | 0 | -9.6% |
| YTD | 72 755 | 102.2% | 100.0% | 0 | 251 506 825 | 98.6% | 100.0% | 0 | 102.2% |
| MAT | 119 448 | 101.9% | 100.0% | 0 | 411 558 107 | 97.4% | 100.0% | 0 | 101.9% |
| GOLDLINE PLUS | |||||||||
| WoW | 13 564 | 7.5% | 47.4% | 0.5 | 45 784 265 | 10.3% | 39.5% | 1.4 | 6.3% |
| MoM | 59 170 | -11.1% | 46.8% | 1.5 | 194 213 502 | -9.7% | 38.4% | 1.6 | -13.9% |
| YTD | 489 926 | -6.7% | 45.8% | 0.9 | 1 583 134 148 | -4.4% | 37.5% | 0.7 | -8.5% |
| MAT | 793 905 | -6.1% | 46.0% | 0.5 | 2 530 748 232 | -5.4% | 37.6% | -0.3 | -7.1% |
| MIGRENIUM | |||||||||
| WoW | 7 610 | 4.9% | 0.3% | 0 | 2 714 858 | 4.8% | 0.4% | 0 | 1.7% |
| MoM | 33 596 | -4.9% | 0.3% | 0 | 11 944 032 | -4.5% | 0.4% | -0.1 | 6.0% |
| YTD | 250 661 | -31.0% | 0.3% | -0.2 | 88 242 240 | -21.3% | 0.5% | -0.2 | 5.5% |
| MAT | 455 311 | -26.2% | 0.4% | -0.1 | 157 744 642 | -4.0% | 0.5% | -0.1 | 1.8% |
| MODELAX-N | |||||||||
| WoW | 25 085 | 3.9% | 19.3% | 0.7 | 14 057 751 | 3.6% | 14.1% | 0.5 | 0.1% |
| MoM | 109 558 | -17.1% | 18.9% | -4.5 | 61 104 818 | -14.6% | 13.7% | -3.1 | 2.8% |
| YTD | 877 913 | -3.6% | 20.2% | -2.8 | 468 976 221 | 19.9% | 14.5% | -0.2 | 9.8% |
| MAT | 1 430 930 | 2.0% | 20.1% | -1.1 | 737 125 519 | 31.4% | 14.1% | 1.1 | 7.4% |
| REDUXIN | |||||||||
| WoW | 9 112 | 7.1% | 31.9% | 0.3 | 49 364 705 | 4.8% | 42.6% | -0.7 | 6.3% |
| MoM | 39 941 | -15.6% | 31.6% | -0.6 | 216 342 541 | -16.7% | 42.8% | -1.6 | -13.9% |
| YTD | 338 243 | -12.1% | 31.6% | -1.3 | 1 844 254 772 | -10.6% | 43.6% | -2.1 | -8.5% |
| MAT | 549 048 | -8.7% | 31.8% | -0.5 | 2 945 468 299 | -6.0% | 43.8% | -0.6 | -7.1% |
| REDUXIN FORTE | |||||||||
| WoW | 2 921 | 2.2% | 10.2% | -0.4 | 13 940 376 | 3.2% | 12.0% | -0.4 | 6.3% |
| MoM | 13 181 | -11.7% | 10.4% | 0.3 | 61 917 260 | -8.5% | 12.2% | 0.7 | -13.9% |
| YTD | 107 646 | 4.7% | 10.1% | 1.3 | 491 935 065 | 10.4% | 11.6% | 1.7 | -8.5% |
| MAT | 172 169 | 3.6% | 10.0% | 1 | 767 966 746 | 8.3% | 11.4% | 1.4 | -7.1% |
| SALVISAR | |||||||||
| WoW | 8 442 | 3.6% | 1.3% | 0.1 | 4 520 205 | 3.2% | 1.3% | 0.1 | -1.6% |
| MoM | 37 734 | -12.3% | 1.3% | -0.1 | 20 254 565 | -11.7% | 1.3% | -0.1 | -3.9% |
| YTD | 368 950 | 18.7% | 1.7% | 0.3 | 185 523 167 | 46.7% | 1.6% | 0.4 | -2.3% |
| MAT | 629 795 | 25.2% | 1.7% | 0.4 | 300 032 165 | 57.4% | 1.6% | 0.5 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 276 543 | 23.3% | 13.1% | 1.6 | 615 025 058 | 27.2% | 9.8% | 0.4 | 8.0% |
| BRAINMAX | 72 755 | 102.2% | 100.0% | 0 | 251 506 825 | 98.6% | 100.0% | 0 | 102.2% |
| GOLDLINE PLUS | 489 926 | -6.7% | 45.8% | 0.9 | 1 583 134 148 | -4.4% | 37.5% | 0.7 | -8.5% |
| MIGRENIUM | 250 661 | -31.0% | 0.3% | -0.2 | 88 242 240 | -21.3% | 0.5% | -0.2 | 5.5% |
| MODELAX-N | 877 913 | -3.6% | 20.2% | -2.8 | 468 976 221 | 19.9% | 14.5% | -0.2 | 9.8% |
| REDUXIN CAPS | 338 243 | -12.1% | 31.6% | -1.3 | 1 844 254 772 | -10.6% | 43.6% | -2.1 | -8.5% |
| REDUXIN FORTE | 107 646 | 4.7% | 10.1% | 1.3 | 491 935 065 | 10.4% | 11.6% | 1.7 | -8.5% |
| SALVISAR | 368 950 | 18.7% | 1.7% | 0.3 | 185 523 167 | 46.7% | 1.6% | 0.4 | -2.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 473 622 | 25.5% | 13.2% | 2.6 | 970 736 596 | 22.3% | 9.6% | 0.7 | 0.5% |
| BRAINMAX | 119 448 | 101.9% | 100.0% | 0 | 411 558 107 | 97.4% | 100.0% | 0 | 101.9% |
| GOLDLINE PLUS | 793 905 | -6.1% | 46.0% | 0.5 | 2 530 748 232 | -5.4% | 37.6% | -0.3 | -7.1% |
| MIGRENIUM | 455 311 | -26.2% | 0.4% | -0.1 | 157 744 642 | -4.0% | 0.5% | -0.1 | 1.8% |
| MODELAX-N | 1 430 930 | 2.0% | 20.1% | -1.1 | 737 125 519 | 31.4% | 14.1% | 1.1 | 7.4% |
| REDUXIN CAPS | 549 048 | -8.7% | 31.8% | -0.5 | 2 945 468 299 | -6.0% | 43.8% | -0.6 | -7.1% |
| REDUXIN FORTE | 172 169 | 3.6% | 10.0% | 1 | 767 966 746 | 8.3% | 11.4% | 1.4 | -7.1% |
| SALVISAR | 629 795 | 25.2% | 1.7% | 0.4 | 300 032 165 | 57.4% | 1.6% | 0.5 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 672 | 3.0% | 14.1% | 0.4 | 17 856 593 | 2.7% | 10.7% | 0.3 | -0.1% |
| BRAINMAX | 1 878 | 3.6% | 100.0% | 0 | 6 570 590 | 5.5% | 100.0% | 0 | 3.6% |
| GOLDLINE PLUS | 13 564 | 7.5% | 47.4% | 0.5 | 45 784 265 | 10.3% | 39.5% | 1.4 | 6.3% |
| MIGRENIUM | 7 610 | 4.9% | 0.3% | 0 | 2 714 858 | 4.8% | 0.4% | 0 | 1.7% |
| MODELAX-N | 25 085 | 3.9% | 19.3% | 0.7 | 14 057 751 | 3.6% | 14.1% | 0.5 | 0.1% |
| REDUXIN CAPS | 9 112 | 7.1% | 31.9% | 0.3 | 49 364 705 | 4.8% | 42.6% | -0.7 | 6.3% |
| REDUXIN FORTE | 2 921 | 2.2% | 10.2% | -0.4 | 13 940 376 | 3.2% | 12.0% | -0.4 | 6.3% |
| SALVISAR | 8 442 | 3.6% | 1.3% | 0.1 | 4 520 205 | 3.2% | 1.3% | 0.1 | -1.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 35 432 | -4.8% | 14.0% | 0.2 | 82 298 386 | -4.1% | 10.7% | 0.2 | -6.4% |
| BRAINMAX | 8 367 | -9.6% | 100.0% | 0 | 28 979 330 | -8.5% | 100.0% | 0 | -9.6% |
| GOLDLINE PLUS | 59 170 | -11.1% | 46.8% | 1.5 | 194 213 502 | -9.7% | 38.4% | 1.6 | -13.9% |
| MIGRENIUM | 33 596 | -4.9% | 0.3% | 0 | 11 944 032 | -4.5% | 0.4% | -0.1 | 6.0% |
| MODELAX-N | 109 558 | -17.1% | 18.9% | -4.5 | 61 104 818 | -14.6% | 13.7% | -3.1 | 2.8% |
| REDUXIN CAPS | 39 941 | -15.6% | 31.6% | -0.6 | 216 342 541 | -16.7% | 42.8% | -1.6 | -13.9% |
| REDUXIN FORTE | 13 181 | -11.7% | 10.4% | 0.3 | 61 917 260 | -8.5% | 12.2% | 0.7 | -13.9% |
| SALVISAR | 37 734 | -12.3% | 1.3% | -0.1 | 20 254 565 | -11.7% | 1.3% | -0.1 | -3.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs